Articles |

Colchicine, D-Penicillamine, and Prednisone in the Treatment of Idiopathic Pulmonary Fibrosis : A Controlled Clinical Trial FREE TO VIEW

Moisés Selman; Guillermo Carrillo; Jorge Salas; Rogelio Pérez Padilla; Rosario Pérez-Chavira; Raúl Sansores; Rocío Chapela
Author and Funding Information

From the Instituto Nacional de Enfermedades Respiratorias, México, DF, Mexico

1998 by the American College of Chest Physicians

Chest. 1998;114(2):507-512. doi:10.1378/chest.114.2.507
Text Size: A A A
Published online


Study objective: We compared the long-term efficacy of the combination of colchicine and/or D-penicillamine with prednisone, in comparison to prednisone alone in patients with idiopathic pulmonary fibrosis (IPF).

Design: Nonrandomized prospective study in patients with IPF confirmed by biopsy specimen.

Setting: National Institute of Respiratory Diseases, Mexico.

Patients: Fifty-six IPF patients were included in this study. Patients received either colchicine/prednisone (n=19), D-penicillamine/prednisone (n=11), D-penicillamine/colchicine/prednisone (n=11), or prednisone alone (n=15). Prednisone therapy was started at 1.0 mg/kg/d for 1 month followed by a biweekly taper to a maintenance dose of 15 mg/d. Colchicine was administered at a daily dose of 1.0 mg, and D-penicillamine was given at a daily dose of 600 mg.

Measurements and results: Response to therapy was assessed by changes in lung function test results as measured by total and vital lung capacities, arterial blood gas analysis at rest breathing room air, and survival. No significant differences either in lung mechanics or in arterial gases were found in any group relative to the baseline measurement. Thirteen of the 56 patients died during the first 2 years, and 29 were dead at 5 years follow-up. Comparison of survival curves by Cox regression model showed no statistically significant difference among the four groups. Known side effects attributable to prednisone were more common and severe than those attributable to the other drugs.

Conclusions: Our results suggest that neither colchicine nor D-penicillamine modified the progressive course of prednisone-treated IPF, and that the search for new drugs is imperative.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543